The latest trading session saw Medtronic (MDT) ending at $87.72, denoting a -0.45% adjustment from its last day's close. The stock's change was less than the S&P 500's daily gain of 0.38%. Meanwhile, ...

The study demonstrated that mechanical thrombectomy is a safe and effective method for stroke patients in India, achieving ...

Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation ...

GE HealthCare Technologies gets a buy rating, agreeing with today's Wall Street and SA analyst consensus. Explore more ...

Merck remains a reliable income stock to hold onto for good.

Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential. Read why I ...

The two-year data aligns with previous long-term results, showcasing meaningful and enduring blood pressure decreases.

Boeing CEO Kelly Ortberg faces urgent challenges, including a worker strike. Experts say he should focus communication, trust ...

Sticks and stones may break my bones, but words will never hurt me.” While this mantra may help bruised egos on ...

Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

(Update: Medtronic announced FDA approval for its Affera cardiac mapping and ablation system with the Sphere-9 catheter in October 2024.) Medtronic acquired the Sphere-9 catheter for pulsed field ...

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a ...